Epilepsy, driving and the pharmaceutical industry - Legal responsibility

Medicine and Law

Volumn 21, Issue 3, 2002, Pages 639-650

  Reuben, Wayne ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

AGRANULOCYTOSIS; AMNESIA; APLASTIC ANEMIA; ATAXIA; CAR DRIVING; CENTRAL NERVOUS SYSTEM DISEASE; CONSUMER; DRIVING ABILITY; DROWSINESS; DRUG INDUSTRY; DRUG INFORMATION; EPILEPSY; FATIGUE; GOVERNMENT; HUMAN; LEGAL ASPECT; LEGAL LIABILITY; MEDICAL INFORMATION; MEDICOLEGAL ASPECT; PHARMACIST; PHYSICIAN ATTITUDE; PRESCRIPTION; RESPONSIBILITY; RISK ASSESSMENT; SHORT SURVEY; SIDE EFFECT; SOMNOLENCE; VERTIGO;

EID: 0036402191     PISSN: 07231393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Cacciatore GG. Can a physician sue a pharmaceutical manufacturer when a drug harms a patient? Texas Medicine 1997; 93: 62-4
2. Krumholz A. Driving and epilepsy: A historical perspective and review of current regulations. Epilepsia 1994; 35: 668-74
3. Roads and Traffic Authority, Drivers and Riders Guidelines for Medical Practitioners, 3rd edition. New South Wales, 1993.
4. Landau WM. More on epilepsy and epileptic drivers, Annals of Neurology 1997; 6: 140.
5. Stanaway L. et al. On the road: Epilepsy and driving. NZ Med J 1983; 96: 525-8
6. Writing about medicines for people: usability guidelines and glossary for consumer product information, 1994, Canberra: Department of Human Services and Health